Search Results

You are looking at 41 - 50 of 126 items for :

  • "Bladder cancer" x
Clear All
Full access

M. j k MD, MBA Hersh Janis l MBA Provenzale Dawn a e i MD, MS 04 2013 11 11 4 4 431 431 441 441 0110431 10.6004/jnccn.2013.0058 Bladder Cancer Clark Peter E. MD Agarwal Neeraj MD Biagioli Matthew C. MD, MS

Full access

David D. Chism

patients diagnosed with non–muscle-invasive bladder cancer (N-MIBC), nearly a quarter experience progression to muscle-invasive bladder cancer (MIBC), which is the more aggressive phenotype. Approximately one-third of newly diagnosed patients will have MIBC

Full access

Scott M. Gilbert and Brent K. Hollenbeck

curative resection of colon cancer: systematic review . J Natl Cancer Inst 2007 ; 99 : 433 – 441 . 3 Konety BR Joslyn SA O’Donnell MA . Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer

Full access

: 4/11/14 Quality Indicators in the Management of Bladder Cancer Expiration Date: 4/11/14 CASE REPORT: A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management Expiration Date: 5

Full access

Geoffrey MD Dwyer Mary A. MS Gurski Lisa A. PhD 10 2017 15 15 10 10 1240 1240 1267 1267 10.6004/jnccn.2017.0156 Clinical Significance of Histologic Variants of Bladder Cancer Warrick Joshua I. MD 10 2017 15 15 10 10 1268 1268

Full access

/11/14 Quality Indicators in the Management of Bladder Cancer Expiration Date: 4/11/14 CASE REPORT: A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management Expiration Date: 5/13/14 NCCN Guidelines® Insights

Full access

Jonathan L. Vandergrift

example, a 2007 systematic review that examined gemcitabine treatment for bladder cancer identified 28 phase II studies, 3 of which 4 studies are referenced and discussed in version 2.2012 of the NCCN Guidelines for Bladder Cancer (to view the most recent

Full access

Marina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, Thomas Martin, Claudia Collà Ruvolo, Luigi Nocera, Zhe Tian, Frederik C. Roos, Andreas Becker, Luis A. Kluth, Derya Tilki, Shahrokh F. Shariat, Fred Saad, Felix K.H. Chun and Pierre I. Karakiewicz

in the most contemporary imaging guidelines for UTUC. Currently, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer 11 recommend bone imaging in patients with UTUC in the presence of bone symptoms or in patients

Full access

Hamdy A. Azim, Abdul-Rahman Jazieh and Mohammad Jahanzeb

cancers and usually secondary to hepatitis C virus (HCV). 8 In a subgroup analysis of a pivotal sorafenib study, a greater benefit of this drug was seen among patients with HCV-associated HCC. Another example is bladder cancer, which is usually of

Full access

Alison M. Lake and William W. Roberts

urinary tract . J Urol 1997 ; 157 : 1622 – 1624 . 26. Stein JP Skinner DG . The role of lymphadenectomy in high-grade invasive bladder cancer . Urol Clin North Am 2005 ; 32 : 187 – 197 .